HomeIvabradine

Ivabradine

Also known as: Ivabradine

Route: Oral

Check Ivabradine Interactions →
23 interactions on record

Ivabradine has 23 known drug interactions based on U.S. FDA drug labeling data. Of these, 10 are contraindicated combinations that should be avoided entirely. 9 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Clarithromycin, Diltiazem Hydrochloride, Diltiazem Hydrochloride Extended-Release Tablets. Patients taking Ivabradine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
23
Contraindicated
10
Major
9
Moderate
4

Contraindicated (10)

Major (9)

  • Ivabradine + Amiodarone HydrochlorideNegative chronotrope. Potentiates electrophysiologic and hemodynamic effects resulting in bradycardia, sinus arrest, and
  • Ivabradine + BarbituratesCYP3A4 inducers that decrease ivabradine plasma concentrations; avoid concomitant use.
  • Ivabradine + DiltiazemModerate CYP3A4 inhibitor that increases ivabradine plasma concentrations; avoid concomitant use.
  • Ivabradine + Grapefruit JuiceModerate CYP3A4 inhibitor that increases ivabradine plasma concentrations; avoid concomitant use.
  • Ivabradine + PhenytoinCYP3A4 inducer that decreases ivabradine plasma concentrations; avoid concomitant use.
  • Ivabradine + RifampinCYP3A4 inducer that decreases ivabradine plasma concentrations; avoid concomitant use.
  • Ivabradine + SiponimodDrug that may decrease heart rate; treatment with siponimod should generally not be initiated due to additive heart rate
  • Ivabradine + St. John'S WortCYP3A4 inducer that decreases ivabradine plasma concentrations; avoid concomitant use.
  • Ivabradine + VerapamilModerate CYP3A4 inhibitor that increases ivabradine plasma concentrations; avoid concomitant use.

Moderate (4)

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.